A novel homozygous inactivating mutation of the calcium-sensing receptor causing familial hypocalciuric hypercalcemia complicated with primary hyperparathyroidism due to parathyroid adenoma: A case report
Journal of International Medical Research · 2026-03 · 54 (3)
DOI: 10.1177/03000605261429307 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of International Medical Research, online erschienen am 19.03.2026. Verfasst von Xiaoran Tao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The First Hospital of Jilin University, China. Hauptthemen laut MEDLINE: Receptors, Calcium-Sensing, Hypercalcemia, Hyperparathyroidism, Primary, Parathyroid Neoplasms. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Familial hypocalciuric hypercalcemia is an autosomal dominant genetic disorder characterized by mild to moderate hypercalcemia, mild hypermagnesemia, and normal or inappropriately elevated parathyroid hormone levels. Familial hypocalciuric hypercalcemia 1 is the most prevalent form of familial hypocalciuric hypercalcemia and is typically caused by heterozygous loss-of-function mutations in the calcium-sensing receptor (CaSR) gene. Homozygous CaSR mutations are more commonly associated with neonatal severe primary hyperparathyroidism. We report the case of a female patient in her early 40s harboring a novel homozygous frameshift mutation in the CaSR gene (c.2603_2604insTT), resulting in familial hypocalciuric hypercalcemia 1. The patient presented with persistent hypocalciuria, hypercalcemia, and primary hyperparathyroidism, along with a family history of consanguinity. This case highlights the phenotypic variability associated with CaSR mutations and broadens the clinical spectrum of homozygous CaSR -related disorders. Increased clinical awareness of atypical genetic presentations is essential to avoid misdiagnosis and to ensure appropriate management of patients with familial disorders of calcium homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, The First Hospital of Jilin University, China.
ORCID-Profile: Xiaoran Tao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Tao, X., Yin, M., & Gang, X. (2026). A novel homozygous inactivating mutation of the calcium-sensing receptor causing familial hypocalciuric hypercalcemia complicated with primary hyperparathyroidism due to parathyroid adenoma: A case report. Journal of International Medical Research, 54(3). https://doi.org/10.1177/03000605261429307
Vancouver
Tao X, Yin M, Gang X. A novel homozygous inactivating mutation of the calcium-sensing receptor causing familial hypocalciuric hypercalcemia complicated with primary hyperparathyroidism due to parathyroid adenoma: A case report. Journal of International Medical Research. 2026;54(3). doi:10.1177/03000605261429307
BibTeX
@article{Tao2026,
author = {Tao, Xiaoran and Yin, Mengsha and Gang, Xiaokun},
title = {A novel homozygous inactivating mutation of the calcium-sensing receptor causing familial hypocalciuric hypercalcemia complicated with primary hyperparathyroidism due to parathyroid adenoma: A case report},
journal = {Journal of International Medical Research},
year = {2026},
volume = {54},
number = {3},
doi = {10.1177/03000605261429307}
}
EUVIMED